Fig 5.
T3DC S1 coding sequences segregate with resistance to protease-mediated loss of infectivity. Purified virions of T3DF, rsT3DF/T3DCS1-77, rsT3DF/T3DCS1-1234, and rsT3DF/T3DCS1 at a concentration of 5 × 1010 particles/ml were treated with either chymotrypsin (A) or neutrophil elastase (B) at 37°C. Viral titers before and after treatment were determined by plaque assay using L929 cells. Changes in viral infectivity are expressed as the ratio of log10 viral titers at each treatment time relative to mock treatment. Results are shown from a representative experiment of three performed.